Why critical-care injectables are among the hardest medicine...

When hospitals in the United States began delaying elective procedures in 2024 over a shortage of intravenous saline solutions, it exposed a structural vulnerability that rarely makes headl

From pilots to patients: Why the UK must rethink NHS innovat...

At PharmaTech Integrates in Glasgow, speakers from government, academia, the NHS, and pharma sought to define the sector’s path forward.

Safeguarding the pharmaceutical supply chain

The UK can’t just be a life sciences lab – we need manufactu...

Rachel Reeves is right: the UK is at the forefront of life sciences, with some world-leading research and innovation.

From promise to reality: Unlocking the true business potenti...

The genomic medicine space has seen incredible success, but investors are overlooking it.